175 related articles for article (PubMed ID: 11880957)
1. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
Lodise TP; McKinnon PS; Tam VH; Rybak MJ
Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
3. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
4. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
[TBL] [Abstract][Full Text] [Related]
6. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
Erlandson KM; Sun J; Iwen PC; Rupp ME
Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
[TBL] [Abstract][Full Text] [Related]
7. Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.
Hurley JC
Clin Infect Dis; 2005 Nov; 41(10):1541-2. PubMed ID: 16231272
[No Abstract] [Full Text] [Related]
8. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia.
Caballero-Granado FJ; Becerril B; Cuberos L; Bernabeu M; Cisneros JM; Pachón J
Clin Infect Dis; 2001 Feb; 32(4):587-94. PubMed ID: 11181122
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
Zaas AK; Song X; Tucker P; Perl TM
Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
[TBL] [Abstract][Full Text] [Related]
11. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.
Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
J Am Geriatr Soc; 2006 May; 54(5):804-8. PubMed ID: 16696747
[TBL] [Abstract][Full Text] [Related]
13. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.
Furtado GH; Mendes RE; Pignatari AC; Wey SB; Medeiros EA
Am J Infect Control; 2006 Sep; 34(7):447-51. PubMed ID: 16945692
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases.
Choi SH; Lee SO; Kim TH; Chung JW; Choo EJ; Kwak YG; Kim MN; Kim YS; Woo JH; Ryu J; Kim NJ
Clin Infect Dis; 2004 Jan; 38(1):53-61. PubMed ID: 14679448
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.
McNeil SA; Malani PN; Chenoweth CE; Fontana RJ; Magee JC; Punch JD; Mackin ML; Kauffman CA
Clin Infect Dis; 2006 Jan; 42(2):195-203. PubMed ID: 16355329
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant enterococcal bloodstream infection-related mortality: focus on the lack of appropriate therapy.
Nannini EC
Clin Infect Dis; 2006 Apr; 42(8):1203-4; author reply 1204-5. PubMed ID: 16575743
[No Abstract] [Full Text] [Related]
19. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
20. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
Matar MJ; Tarrand J; Raad I; Rolston KV
Am J Infect Control; 2006 Oct; 34(8):534-6. PubMed ID: 17015161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
